Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches.
Recalling firm: Maya Distribution, LLC
Samples collected by public health officials found the presence of Salmonella.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Sep 6, 2019.
Check your package
Compare the exact product and package details with the label you have.
No specific lot or batch information was provided in this FDA record.
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Dragon Ultra Ehanced Indo Extract 4-ct x 500 mg capsules in pouches.
Original FDA recall reason
Samples collected by public health officials found the presence of Salmonella.
Recall details
- Recall number
- F-1458-2018
- Event ID
- 79853
- FDA status
- Terminated
- Initiated
- Mar 20, 2018
- Reported
- May 16, 2018
- Classified
- May 15, 2018
- Terminated
- Sep 6, 2019
- Quantity
- Unknown
- Location
- Salt Lake City, UT, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Telephone
Where it was distributed
Recalled product was distributed to retail stores in AZ, IA, ID, IL, KS, MI, UT, and WY.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.